Event studies are frequently used to estimate average treatment effects on the treated (ATT). In estimating the ATT, researchers commonly use fixed effects models that implicitly assume constant treatment effects across cohorts. We show that this is not an innocuous assumption. In fixed effect models where the sole regressor is treatment status, the OLS coefficient is a non-convex average of the heterogeneous cohort-specific ATTs. When regressors containing lags and leads of treatment are added, the OLS coefficient corresponding to a given lead or lag picks up spurious terms consisting of treatment effects from other periods. Therefore, estimates from these commonly used models are not causally interpretable. We propose alternative estimators that identify certain convex averages of the cohortspecific ATTs, hence allowing for causal interpretation even under heterogeneous treatment effects. To illustrate the empirical content of our results, we show that the fixed effects estimators and our proposed estimators differ substantially in an application to the economic consequences of hospitalization.
Introduction
Rich panel data has encouraged a growing literature of empirical work using difference-in-differences (DID) designs to estimate the average treatment effects among units that receive the treatment (AT T ) in the treatment period. The key identifying assumption is that in the absence of treatment, treated units would have experienced the same trends in average outcomes as the control units (i.e. a parallel trends assumption).
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Event study differs from DID design in that treatment is no longer uniquely characterized by a binary variable. In event studies (where treatment is an absorbing state), treatment is uniquely characterized by the timing of treatment, and we can categorize treated units into cohorts based on when they first receive the treatment. For each cohort, we can define relative time as the time relative to the initial treatment.
Within a cohort, calendar time and relative time are collinear, so we cannot identify dynamic treatment effects in the presence of time trends. However, with multiple cohorts, as in DID, we can separate these two effects by comparing the trends in average outcomes between treated cohorts and cohorts yet to be treated (given a parallel trends assumption). As a result, we can identify causal treatment effects for a given cohort at many different relative times, provided that this cohort is treated for more than one period. We call these cohort-specific average treatment effects on the treated CAT T s. Researchers are often interested in some weighted averages of CAT T s, and their estimates are typically obtained from a linear two-way fixed effects (F E) regression, with both unit fixed effects and time fixed effects. To estimate dynamic treatment effects, researchers add lags of treatment to the regression and interpret the coefficient on a specific lag as a weighted average of CAT T s from the given lag. To gauge whether the parallel trends assumption is plausible, researchers add leads of treatment to the regression and take the coefficients on these leads as evidence for lack of or existence of pre-trends.
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In this paper, we make the following three contributions. First, we cast event studies in a potential outcome framework to discipline possible forms of heterogeneity in CAT T s. Second, we examine the behavior of the linear two-way fixed effects regressions for event studies when CAT T s are allowed to differ across cohorts. We show that the F E estimators can be non-convex averages of CAT T s, and thus not causally interpretable. Lastly, we propose alternative estimators that are guaranteed to estimate convex averages of CAT T s. We close with an empirical example that demonstrates both how and why F E estimators can be misleading in comparison to our suggested alternative estimators.
We begin by providing a potential outcome framework for event studies, and clarify the notion of treatment effects heterogeneity in a dynamic setting, which is specific to event studies. We define the underlying causal parameter of interest as the cohort-specific average treatment effect on the treated (CAT T ). Since cohorts are the level used to identify time trends separately from dynamic treatment effects, they are also the key level of concern for confounding heterogeneity. We can categorize a single cohort's effects as either static or dynamic and the overall effects as either stationary or non-stationary. A cohort has "static" treatment effects when the CAT T is constant over time; in contrast, it is "dynamic" when the treatment effect evolves over time. Treatment effects are "stationary" when the the CAT T is the same across all cohorts for a given relative time; otherwise the effects are said to be non-stationary, which can be interpreted as heterogeneity 1 Such practice can be considered as an extension to the Granger causality model popular in DID designs.
in a dynamic setting.
Building on the potential outcome framework, we derive the estimands for conventionally used F E estimators and find that they do not necessarily identify convex averages of CAT T s, and therefore do not identify an interpretable causal effect. These two-way fixed effects models come in two varieties: static and dynamic. In the static model, the only regressor other than fixed effects is an indicator for a unit being treated at time t. Similar to Borusyak and Jaravel (2017) and de Chaisemartin and D'Haultfoeuille (2018), we find that while this F E estimator estimates a weighted average of CAT T s across all cohorts and relative times, the weights can be non-convex and thus do not correspond to an overall causal effect.
In the dynamic model, researchers include leads and lags of the treatment indicator. When treatment effects are dynamic and heterogenous, we find the dynamic model also does not return interpretable estimates of causal effects. The estimator associated with a particular lead (or lag) l, does not necessarily estimate a weighted average of CAT T s associated with l; instead, it may pick up spurious terms consisting of treatment effects from periods other than l.
2 This cautions against interpreting the lead coefficient estimates as (lack of) a pre-trend, and the lag coefficient estimates as lagged treatment effects. We propose an alternative estimator that is guaranteed to estimate a convex average of CAT T s from the corresponding relative time l. These estimators are based on an interacted model that is saturated in relative time and cohort indicators which is first used to estimate CAT T s. Then we pick the CAT T s associated with l to form a weighted average, with weights equal to the share of each cohort. These alternative estimates are thus causally interpretable.
To our knowledge, the negative results regarding the dynamic model have not been documented.
We demonstrate the empirical relevance of our negative finding regarding the dynamic F E model by reestimating the economic consequences of hospitalization seen in Dobkin et al. (2018) for an elderly sample.
We study hospitalization in a subsample of the Health and Retirement Survey (HRS), consisting of 2,813 patients across five waves of survey (roughly 2004-2012, biennially) , and estimate the effect of hospitalization on out-of-pocket medical spending and on labor earnings. In this context we think stationarity might be violated because individuals gradually age into Medicare and retirement, thus we expect the treatment effect may change over time. Using our alternative estimator we find that hospitalization increases out-of-pocket medical spending and decreases labor earnings, similar to the results of Dobkin et al. (2018) . In contrast, we
show that the FE estimator gives results of the opposite sign, suggesting hospitalization decreases medical spending and increases labor earnings. This example illustrates how F E estimates can lead to misleading results in the presence of dynamic and heterogeneous treatment effects.
In the next section, we relate our findings to the previous literatures on estimating treatment effects of a time-varying treatment. Section 2 introduces the potential outcome framework for event studies. Following that, we derive the asymptotic behavior of the F E estimators and present the negative results on them.
Section 4 develops our alternative estimators. Section 5 discusses applications of our results and Section 6 concludes.
Literature
Our results relate to a number of previous literatures. The literature on estimating treatment effects of a time-varying treatment starts with the marginal structural models developed by Hernán et al. (2001) .
They take a selection-on-observables approach, by assuming sequential randomization conditional on timevarying observable confounders. Event studies typically allow for unobserved time-invariant and separable confounders. By assuming the timing of treatment is exogenous to the growth in outcome if never treated, the timing can depend on unobserved time-invariant confounders in an unrestricted form, as long as they are separable and can be differenced out.
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Our analysis contributes to the literature analyzing linear two-way fixed effects models (de Chaisemartin and D'Haultfoeuille, 2018 and Kim and Imai, 2017) . de Chaisemartin and D'Haultfoeuille (2018) focus on a setting where treatment groups are defined by the evolution of treatment rate. For example, the treated group experiences a larger increase in treatment rate than the control group between two time periods. They find that the F E estimator estimates a weighted average of local average treatment effects (LAT E) in each treatment group, under the assumption that treatment effects are not dynamic. That is, they assume the LAT E for each treatment group does not vary after treatment. Kim and Imai (2017) focus on a setting where treatment groups are defined by their treatment history. Under the assumption that treatment has no lasting effect beyond the period of initial treatment, they find that the F E estimator estimates a weighted average of average treatment effects in each treatment group. While we show similar results that the F E estimator estimates a weighted average of average treatment effects in each cohort, due to the structure of event studies, we are able to relax their assumptions on treatment effects.
In event studies, we are able to identify average treatment effects on the treated in each cohort (CAT T ) instead of LAT E because cohorts experience sharp increases in treatment rate. Borusyak and Jaravel (2017) focus on event studies and find that when treatment effects are dynamic but homogeneous across cohorts, the F E estimator in the static model could weight long-run treatment effects negatively when no leads or lags of treatment are included in the specification. We show a similar result when treatment effects are allowed to be heterogeneous, and our negative results extend to the specification with leads and lags of treatment. The F E estimators for pre-trends are likely to assign non-zero weight on treatment effects post-treatment, which can yield non-zero pre-trends estimates even though there are no pre-trends. The F E estimators for l lags to treatment are likely to be a non-convex average of CAT T s from l periods after initial treatment, as well as CAT T s from other periods, which can yield an estimate with the opposite sign to any CAT T s from l periods after initial treatment. These negative results have not been documented to our knowledge, and we illustrate their relevance using both a simulation example and an empirical application.
2 Event studies in a potential outcome framework
We assume a balanced panel of N units and T + 1 time periods with no missing data. We also assume a simple random sampling of units with T fixed. For each unit i = 1, . . . , N at time t = 0, . . . , T , we observe an outcome variable Y i,t and a binary treatment status variable D i,t ∈ {0, 1}: D i,t = 0 if i has not been treated by period t and D i,t = 1 if i has been treated by period t.
For each unit we observe a treatment path
. In event studies, treatment is an absorbing state and the treatment path is a non-decreasing sequence of zeros and then ones. Thus, the treatment path of a unit can be uniquely characterized by the time period of the initial treatment, identified with the scalar random variable E i = min {t : D i,t = 1}. We call this random variable E i "event time" as it refers to the onset of the treatment. In our notation, cohort e is the set of units for which E i = e. Denote E i = ∞ for units never treated.
We assume that in this panel, E i is supported on {1, 2, 3, . . . , T }, so no units are treated in the first period (t = 0) and all units are treated by the last period (t = T ). We assume P r {E i = 0} = 0 since we cannot apply DID estimators for E i = 0 as we see later.
4 Our results extend to the case where we observe units never treated in the panel (possibly treated after the panel E i > T , or a pure control group that is never treated E i = ∞).
Potential outcomes describe realizations of the outcome variable Y i,t that arise in response to a hypothetical treatment path e. We denote the potential outcome in period t under treatment path e by Y e i,t . In particular, Y ∞ i,t is the potential outcome if unit i never receives treatment, which we call "baseline outcome".
We observe each unit under only a single treatment path E i = e, so the observed outcome for unit i is
Identifying assumptions
We maintain the following assumption which makes growth in baseline outcome mean independent of the event time E i . supp (E i ) ∀s, t and in particular, equal to E Y
Another assumption necessary for identification of the causal parameters we are interested in precludes treatment from influencing outcomes before treatment takes place. This assumption is plausible if the full treatment paths are not known to units, so that future treatment cannot affect current potential outcome. However, if the full treatment path is known to the units, then the potential outcome prior to treatment may be affected by future treatments.
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We maintain both Assumption 1 and Assumption 2 throughout our analysis.
Under these two assumptions, we can identify causal parameters CAT T e,l :
the cohort-specific average treatment effects on the treated l periods relative to the initial treatment for cohort e as shown later in Proposition 3. For cohort e, l ranges from −e to T − e because at most we observe e periods before initial treatment and T − e periods after initial treatment. Note that we cannot identify Chernozhukov et al. (2013) without further assumptions.
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This assumption also implies no pre-trends since CAT T e,l = 0 for all l < 0.
Additional assumptions on potential outcomes
We state two additional assumptions that may be imposed on potential outcomes. As we show later, these additional assumptions are necessary for the F E estimators to yield interpretable estimates.
Assumption 3. Static treatment effects. If CAT T e,l = CAT T e,l for all l = l , l, l ≥ 0, then we say treatment effect for cohort e is static; in contrast, if CAT T e,l = CAT T e,l for any l = l , l, l ≥ 0, then we say treatment effect for cohort e is dynamic.
Within a cohort, we can categorize treatment effects as static or dynamic. Static effects impact units immediately upon treatment and on average, persist at the same level for all treated periods. We call the opposite of static effects dynamic. Treatment effects are likely to be dynamic when the treatment of interest is a transient shock (like an adverse health shock which we will explore in our application) or when there is learning from and adaptation to the treatment over time (like switching to a new firm).
Assumption 4. Stationary treatment effects. If CAT T for all l ≥ 0 depends only on l and not on e, then we say treatment effects are stationary; in contrast, if for any l ≥ 0, CAT T e,l varies by e, then we say treatment effects are non-stationary.
We can categorize the overall treatment effects as stationary or non-stationary. Stationary effects mean that on average, each cohort experiences the same effects at any given relative time period. We call the opposite of stationary effects non-stationary, which reflects heterogeneity across cohorts. In an event study, this sort of heterogeneity across cohorts could be driven by time-varying effect. An example of this, which we explore in our application, is that aging into Medicare and retirement could mean the same adverse health shock has a different impact on spending and labor earnings in later waves of the HRS panel.
Linear two-way FE regression models for event studies
Treatment effects in event studies are often estimated by a linear regression with two-way fixed effects containing unit and time fixed effects. There are two common specifications: static and dynamic. The static specification is
where D i,t is the treatment indicator in time period t. The regression coefficient estimator γ is commonly interpreted as an estimator for some weighted average of CAT T e,l 's across all cohorts and all lagged time periods. The other common specification, which we refer to as the dynamic specification, adds leads and lags of treatment to the above specification
Here
,t is an indicator for being l time periods relative to i's initial treatment (l = 0 is the year of initial treatment). 7 The lagged coefficient estimator µ l for some l ≥ 0 is commonly interpreted as an estimator for some weighted average of CAT T e,l 's across all cohorts e that experience at least l periods of treatment. The regression coefficient estimators µ l for l < 0 are commonly interpreted as estimators for pre-trends.
Below we show that while these F E estimators do estimate weighted averages of causal parameters
CAT T e,l 's, the weights are in general unreasonable and need not be positive without additional assumptions that restrict treatment effects to be static or stationary. These negative results caution us against always interpreting the F E estimates as estimates for some convex averages of CAT T e,l 's. We first focus on the static F E estimator and present a result similar to Borusyak and Jaravel (2017) and de Chaisemartin and D'Haultfoeuille (2018).
Proposition 1. (Probability limit of the static FE estimator). DenoteD
T +1 . Under Assumption 1 and 2, the regression coefficient estimator γ from (2) converges in probability to
where the weight is ω e,l := P r {E i = e}
(1−D·,e+l−De,·+D)
Proposition 1 reveals that, while the static F E estimator converges to a weighted average of CAT T e,l 's, the weights generally do not coincide with sample frequencies. The numerator of the weight, 1 −D ·,e+l − D e,· +D, is the residual from predicting treatment status D i,t with unit and time fixed effects. It thus downweights (to the point of potentially negatively weighting) the long-run treatment effects (large l) for cohorts with an early onset of treatment (small e) because the fixed effects would overpredict their treatment probability.
As a concrete example, if all units are treated at some time within the panel, some weights will necessarily be negative. Since all units have been treated by the final period, we haveD ·,T = 1. Furthermore,D e,· >D for cohorts treated in the early half of the panel (e < E[E i ]). So the weights associated with CAT T e,T −e 's for these cohorts in the last period are all negative. γ would then estimate a non-convex average of CAT T e,l 's.
Its probability limit will be further from a convex average when the CAT T e,l 's associated with negative weights are of large magnitude, and can even drive the the sign of γ to be the opposite to the majority of CAT T e,l 's.
Special Case: Static and Stationary Treatment Effects. From Proposition 1, we can also see that when treatment effects are static and stationary for all cohorts, the F E estimator γ will estimate the causal effect of interest. With those strict assumptions, the CAT T e,l does not depend on e nor l so we can move it outside of the summation and we know the weights sum to one; thus the static F E estimator would give a reasonable result as it converges to a constant CAT T .
Next we present the probability limits of dynamic F E estimators without any restriction on treatment effects. To our knowledge, no paper has yet to study the dynamic specification when treatment effects are dynamic and heterogenous.
Proposition 2. (Probability limits of the dynamic FE estimators). Under Assumption 1 and 2, the lagged FE estimator µ l for some l ≥ 0 converges in probability to a weighted average of post-treatment CAT T e,l for all l = l,
where −l≤e≤T −l ω l e,l = 1 and for each l = l, −l ≤e≤T −l ω l u,l = 0. The lead FE estimator µ l for some l < 0 converges in probability to a linear combination of post-treatment CAT T e,l for all l ≥ 0,
where for each l , −l ≤e≤T −l ω and two-way fixed effects.
The above proposition yields two negative results. First, Proposition 2 shows that the lagged F E estimators µ l for l ≥ 0 average treatment effects across cohorts from multiple times periods: CAT T e,l 's as well as CAT T e,l 's for l = l. Therefore, µ l is not isolating the average treatment effects l periods after initial treatment, but rather estimating an affine combination of effects from multiple periods.
Second, lead F E estimators µ l for l < 0 do not converge to zero even when there are no pre-trends by assumption. Due to the influence of post-treatment CAT T e,l 's for l ≥ 0, µ l does not necessarily converge to zero even though under the no anticipation assumption, CAT T e,l = 0 for all l < 0 and all e so any weighted average of CAT T e,l 's should be zero.
We demonstrate the negative result on lead F E estimators µ l for l < 0 through simulation. 8 We estimate (3) on 1000 simulated panel datasets with T = 3 and uniformly distributed E i ∈ {1, 2, 3}. We exclude anticipatory behavior by setting
We set post-treatment treatment effects to be all positive and grow in time. Even though pre-treatment treatment effect is set to zero, the estimatesμ −1 's are usually negative as shown in Figure 1 , which would suggest a negative pre-trend. Even though here we picked an extreme case where both post-treatment CAT T e,l 's and ω l u,l are set to be large to illustrate the negative result, we show that in our application, ω l u,l are large as well and cannot be ignored. Notes: This figure plots the histogram ofμ −1 , the F E estimate for the effect of treatment one period before treatment, across 1000 simulated samples.
Special Case: Stationary Treatment Effects. In the special case of stationary effects, CAT T e,l is constant across e for a given l. The F E dynamic estimators thus recover causally interpretable estimates: the lagged F E estimators µ l for l ≥ 0 converges to CAT T e,l and the lead F E estimators µ l for l < 0 converges to zero. Otherwise, it is problematic to interpret a non-zero estimates on D l i,t for l < 0 as (lack of) evidence for pre-trends because non-zero post-treatment CAT T e,l can affect the lead F E estimators.
8 See Appendix B for more details on the simulation design.
We propose a new specification for estimating the dynamic treatment effects in event studies as an alternative to Regression (3). Unlike the dynamic FE estimators, these alternative estimators are weighted averages of CAT T e,l 's with reasonable weights.
Recall that Proposition (2) implies that under stationary treatment effects when CAT T e,l 's are constant for a given l, Regression (3) is the correct specification and µ l consistently estimates CAT T e,l . Without stationarity when CAT T e,l varies by e, the error term i,t involves the difference between CAT T e,l and
CAT T e ,l for e = e , which is correlated with the unit fixed effects. This hints at using an interacted model, Before introducing the IW estimators formally, we define the DID estimator for CAT T e,l as
for some s < e and C ⊆ {c : e + l < c ≤ T }. Here we use the notion E N to abbreviate the symbol
. This estimator is the difference between the average change in outcomes for cohort e, which is exactly l periods relative to treatment, and average change in outcomes for cohorts that have not been treated by t = e + l. We refer to this set of cohorts as the control cohorts.
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The DID estimator is an unbiased and consistent estimator for CAT T e,l , a fact that we build on in showing the probability limit of the IW estimator. We state this in the following proposition.
Proposition 3. Under Assumption 1 and 2, the DID estimator is an unbiased and consistent estimator for
Proof. Provided that the conditional expectations exist, the DID estimator is an unbiased and consistent
. To show that it is an unbiased and consistent
9 When we do not observe E i = ∞, we cannot estimate E[Y i,t − Y ∞ i,t |E i ] for t = T or E i = T using DID estimators because everyone is treated in the last period and C = ∅. Similarly, we cannot estimate E[Y i,t − Y ∞ i,t |E i = 0] using DID estimators because we do not observe s < 0.
Since s < e and c > e + l, we have
where the second equality follows from Assumption 2 and the fourth equality follows from Assumption 1.
Note that under Assumption 2, Assumption 1 has many testable implications. There are more than one DID estimators for CAT T e,l since we can set different s < e and take subsets of {c : e + l < c ≤ T } as the control cohorts. One can thus form an omnibus test for the validity of these two assumptions. See Callaway and Sant'Anna (2018) for one such test.
It is also possible to relax the parallel trends assumption to allow the timing of treatment to depend on covariates. We state the conditional parallel trends assumption in Appendix C, and present the doubly robust scores for estimating CAT T e,l consistently and efficiently as an extension to the inverse propensity score reweighted estimator proposed by Abadie (2005) and Callaway and Sant'Anna (2018).
Interaction-weighted estimators
Definition 1. The dynamic interaction-weighted (IW ) estimator for a weighted average of CAT T e,l 's is found by first estimating the following specification
on t = 0, . . . , T − 1. 10 Here B i,t is a column vector collecting 1{E i = e} · D l i,t , for 1 ≤ e ≤ T − 1 and for each e, 1 − e ≤ l ≤ T − e. Similarly, δ is a column vector collecting the coefficients δ e,l on
The IW estimator is given by a weighted average of the estimates δ e,l 's:
We need to drop time period T because CAT T e,T 's are not identified. See footnote 9 for more details.
where f l is a matrix with its (t, e) th entry equal to P t,e . Here P t,e = 1 {t − e = l}
Ne and N e = N i=1 1 {E i = e}. For example, for T = 3 and l = 0,
Lastly, we collect all vectorized f l 's in f . We can thus write ν = ( ν 1−T , . . . , ν T −1 ) = f δ, which converges to ν = f δ.
Proposition 4. (Probability of the IW estimators for dynamic treatment effects).
Under Assumption 1 and 2, the IW estimator converges in probability to
Note that δ e,l from Regression (5) is in essence a DID estimator for CAT T e,l in the form of (4) with s = 0 and C = {T }, which is consistent. Thus, ν l is consistent for a weighted average of CAT T e,l with weights equal to the share of cohort e across cohorts that have experienced at least l periods of treatment. These weights are guaranteed to be convex and have a reasonable interpretation.
Among all possible DID estimators for CAT T e,l , δ e,l might not be the most efficient one: suppose Y ∞ i,t follows an AR(1) process with positive correlation, then a possibly more efficient DID estimator sets s = u−1, C = {c, u + l < c}, and weights each cohort c by their precision.
11 That said, we recognize that Regression (5) is easy to implement compared to other more efficient estimators.
We can similarly form an estimator alternative to the static F E estimator from Regression (2) by
e=1 N e 0≤l≤T −1−e 1 T − e δ e,l .
This estimator consistently estimates a weighted average of CAT T e,l 's, with weights proportional to the representativeness of each CAT T e,l , a result stated in the following proposition.
Proposition 5. (Probability of the IW estimator for overall treatment effects). Under Assumption 1 and 2, the IW estimator converges in probability to
CAT T e,l 11 Under random sampling, the variance of the DID estimator is the sum of variance of g l and g ∞ . Note that the variance of Y ∞ i,t − Y ∞ i,s decrease in |t − s|, which suggests we set s = u − 1. Suppose the variance of Y ∞ i,t − Y ∞ i,s differs across cohorts, then the variance of g ∞ is minimized when we weight each cohort c by the inverse of its variance.
Finally, we derive the asymptotic distribution for the dynamic F E and IW estimators. For simplicity, we assume that like Regression (5), Regression (3) is also estimated on t = 0, . . . , T − 1.
Proposition 6. (Asymptotic distribution of the dynamic FE and IW estimators). Under standard assumptions, the asymptotic distribution of the estimators is
where
VBf
We use the notationẌ i,t to denote X i,t − X i,· − X ·,t + X, where
In the presence of non-stationary treatment effects, the saturated specification (5) may reduce standard errors of residuals due to better fit. The IW estimators may thus be more precise. Under stationary treatment effects when both the dynamic F E and IW estimators are consistent for CAT T e,l , which are constant across e for a given l. The dynamic F E estimator might have smaller variance because specification (3) estimates less coefficients. There is established efficiency gain when specification (3) is a "grouped" version of specification (5) 
Applications
We illustrate the empirical importance of our findings by extending the analysis by Dobkin et al. (2018) .
We use both F E and IW estimators to estimate the impact of hospital admissions on out-of-pocket medical spending and labor earnings using a subsample of respondents from the Health and Retirement Survey (HRS). We show that the F E estimators produces statistically insignificant results with point estimates of the "wrong" sign; the F E estimates suggest that hospital admissions may decrease out-of-pocket medical spending and increase earnings for the elderly. In contrast, we show that estimates of CAT T e,l 's are of the expected signs and consequently the IW estimator recovers that hospitalization increases out-of-pocket medical spending right after hospitalization and decreases long-run labor earnings.
Settings
Our sample selection follows Dobkin et al. (2018) but we include a cursory explanation here for completeness.
Our primary source of data is the biennial Health and Retirement Survey (HRS). We identify the sample of individuals who appear in two sequential waves of surveys and newly report having a hospital admission over the last two years (the "index" admission) at the second survey. To focus on health "shocks", we restrict attention to non-pregnancy-related hospital admissions. We restrict our analysis to a subsample of these individuals who appear throughout waves 7-11 (roughly 2004-2012) to maintain a balanced panel with a reasonable sample size.
12 Our sample of analysis therefore includes HRS respondents with index hospitalization during wave 8-11. Here i naturally indexes individual, and t indexes survey wave (T = 4) and is normalized to zero for wave 7, the first wave in our sample.
The treatment status D i,t is thus an indicator for whether a respondent has had an unexpected hospitalization by wave t. We think hospitalization is an absorbing state because it approximates the start of a sick state (as opposed to a healthy state). Thus, event study is an appropriate research design as it allows for lasting treatment effect of hospitalization. Our outcomes of interest Y i,t include out-of-pocket medical spending and labor earnings. They are derived from self-reports, adjusted to 2005 real dollar value and censored at the 99.95th percentile.
In our terminology, we categorize individuals into cohorts based on E i , which is defined as the survey wave of their index hospitalization. Since we restrict the sample to individuals who were ever hospitalized between wave 8-11, E i ∈ {1, 2, 3, 4}.
Parallel trend assumption Hospitalization is likely to be earlier among sicker individuals with high out-of-pocket medical spending and low labor earnings, even when restricted to individuals who were ever hospitalized. Thus, it is not plausible that the baseline outcome Y ∞ i,t is mean independent of the timing of hospitalization. Parallel trends assumption is more plausible as it allows the timing to depend on unobserved time-invariant characteristics such as chronic disease.
it is also plausible that there is no anticipatory behavior.
Potential treatment effects heterogeneity
The effect on out-of-pocket medical spending is largely determined by generosity of health insurance, which has possibly decreased as individuals age into Medicare.
The effect on labor earnings is affected by the labor market: for example, individuals hospitalized during the financial crisis may find it more difficult to return to the labor force, and suffer a more grave decrease in earnings. We suspect these sources of non-stationarity may be exacerbated in this sample because the elderly population has experienced the especially rapid change in healthcare spending and labor participation over time. Table 1 presents basic summary statistics for our analysis sample before hospitalization. By design, our sample is older than that of Dobkin et al. (2018) because Dobkin et al. (2018) restricts to non-elderly adults with ages 50-59 at the time of index hospitalization. Other demographic differences between our sample and that of Dobkin et al. (2018) align with expectations based on the differences in age.
Summary Statistic
We have a slightly lower fraction of men in our sample, as well as a higher fraction white and lower fraction black. Many individuals have also aged into Medicare coverage (for which the qualifying age is 65).
In We estimate the following two specifications without survey weights. For the linear two-way F E regression in the spirit of equation (3), we estimate
for t = 0, . . . , 4. For the saturated model in the spirit of (5), we estimate
for t = 0, . . . , 3. We drop t = 4 from (8) because everyone has had hospitalization by t = 4 , and CAT T e,l 's in t = 4 are not identified. We estimate the above specifications with Y i,t equal to out-of-pocket medical spending as well as labor earnings.
Results and Discussion
Figure 2 compares the dynamic F E estimates of the impact of hospitalization with the IW estimates for two outcomes: out-of-pocket medical spending and labor earnings. The IW estimates show qualitatively similar results to Dobkin et al. (2018) . The effect on out-of-pocket spending is significant and positive for l = 0 (roughly 1 year after hospitalization). The effect on earnings becomes significantly negative starting in l = 1 (roughly 3 years after hospitalization) and remains large for l = 2. In contrast, the dynamic F E estimates are all statistically insignificant, even though the underlying CAT T e,l 's are mostly precisely estimated. Furthermore, the F E point estimates are of the opposite signs of the IW estimates, which are unreasonable as they suggest that out-of-pocket medical spending decrease while earnings increase after hospitalization. Notes: Each figure plots F E estimates µ l (from (7)) in maroon triangles and IW estimates ν l (from (8)) in blue circles against relative time l, with their respective 95% confidence intervals. Recall that ν l are constructed as the weighted average of δ e,l 's. The outcome variable is out-of-pocket medical spending in Panel A and labor earnings in panel B.
In Table 2 , we report the F E estimates µ l and the IW estimates ν l , as well as the underlying CAT T e,l estimates δ e,l . While not reported, we fail to reject the joint hypothesis of parallel trends and no anticipation based on a Wald test for
The IW estimates ν l are weighted averages of estimates for CAT T e,l , with weights equal to the share of cohort e across cohorts that experience at least l periods of treatment. Therefore by construction, the IW estimate falls within the convex hull of the CAT T e,l estimates and has an interpretation as an average effect of the treatment l periods after initial treatment. In contrast, the F E estimates are not within the convex hull of the CAT T e,l estimates and thus do not have a causal interpretation. Notes: This table reports three different sets of estimates for the dynamic effects of hospitalization on outof-pocket medical spending (panel A) and labor earnings (panel B). The first column reports estimates from the F E estimator µ l as in (7). Columns 3-5 report the estimates for CAT T e,l from δ e,l as in (8). Column 2 reports the IW estimates which are constructed as the weighted average of δ e,l across cohorts e who have experienced l periods of treatment. Standard errors (clustered on the individual) are shown in parentheses.
The reason for the dynamic specification to produce wrong-signed and imprecise estimates is thatμ l 's are sensitive to effects from other time periods. Recall by Proposition (2), the probability limit ofμ l iŝ
and the point estimateμ l is the sample analog of (9). For l = 0, we can estimate the weights ω weights are large for leads of treatments (negative relative waves), which suggest that the point estimate µ 0 is particularly sensitive to estimates of pre-trends, and does not isolate the contemporaneous effect of hospitalizations.
13 While we just showed that there is likely no anticipation and in the limit,μ 0 is not affected by pre-trends since all pre-trends CAT T e,l = 0 ∀l < 0, in finite samples, their estimates δ e,l ∀l < 0
are not necessarily zero and can influenceμ 0 if their weights are non-negligible as shown in Figure 3 . (9) implies that µ 0 is a weighted average of δ e,l , estimates for CAT T e,l . This figure plots these weights ω 0 e,l in forming the F E estimate µ 0 .
Conclusions
Linear two-way fixed effects (F E) regressions are commonly used to estimate dynamic treatment effects in event studies. Their behavior has not been closely studied when treatment effects are non-stationary, i.e.
there is heterogeneity in treatment effects across cohorts. The main goal of this paper is to analyze the 13 To see this, note the DID estimator δ 4,l and δ e,−e are all normalized to zero. While δ e,T −3 are not shown in Table 2 above, they receive small weights in formingμ 0 . Thus, one can take the inner product of weight estimates ω 0 e,l from Figure 3 and δ e,l from Table 2 to confirm that the result is similar toμ 0 . In particularly, δ 3,−2 , δ 2,−1 and δ 2,−1 receive positive weights, and δ 1,1 and δ 2,1 receive negative weights, which explains whyμ 0 are likely to have signs closer to the pre-trends estimates and to the negative of estimates of long-run effects.
behavior of F E estimators under heterogeneous treatment effects. We first cast event studies in a potential outcome framework and show the causal parameters, cohort-specific average treatment effects on the treated (CAT T e,l ), are identified under parallel trends and no anticipation assumptions. We clarify the notion of heterogeneity in a dynamic setting: CAT T e,l 's evolves differently across cohorts, such that at a given lag, CAT T e,l varies by e.
Building on the potential outcome framework, we derive asymptotic distribution of F E estimators and show they converge to weighted averages of CAT T e,l 's. The weights sum to one but need not be positive.
This means when treatment effects are dynamic or heterogenous, the static F E estimate may not correspond to a causal effect as its estimand may fall outside the convex hull of CAT T e,l 's. In the dynamic specification, the situation is even worse: under heterogeneous treatment effects, in addition to non-convex weights, the F E estimator associated with l periods relative to initial treatment may pick up spurious terms consisting of treatment effects form periods other than l. Researchers can easily verify the robustness of their F E estimators by estimating these underlying weights.
Given the negative results on F E estimators, we propose "interaction-weighted" (IW ) estimators for estimating dynamic treatment effects in event studies. These estimators are formed by first estimating CAT T e,l 's with a regression saturated in cohort and relative time indicators, and then average estimates of CAT T e,l 's across e at different l's. These estimators are easy to implement and robust to heterogenous treatment effects: the IW estimator associated with relative time l is guaranteed to estimate a convex average of CAT T e,l 's, with weighting being share of each cohort e.
Finally, we illustrate the empirical relevance of our results by estimating the economic consequence of hospitalization on the elderly using the Health and Retirement Survey. We compare F E estimates with IW estimates of the dynamic effects of hospitalization. We find that IW estimates are of the correct sign and more precise relative to F E estimates. We estimate the weights in forming F E estimates and show they are non-convex. As an example, the F E estimate of contemporaneous effects is sensitive to pre-trends estimates and negatively influenced by long-run effects, which makes it causally uninterpretable.
Proof of Proposition 1
Proof. Partialling out the unit and time fixed effects, Regression (2) is Y i,t = γD i,t + i,t whereẌ i,t is time-and cross-sectional demeaned version of X i,t i.e.Ẍ i,t = X i,t −X ·,t −X i,· +X, and
It is easy to see that forẌ i,t andZ i,t , demeaned versions of X i,t and Z i,t respectively, we have E Ẍ i,tZi,t = E X i,tZi,t = E Ẍ i,t Z i,t . The projection coefficient on D i,t from (2), i.e. the probability of the coefficient estimator γ, is then
when t ≥ e,D i,t = 1 and when t < e, D i,t = 0 ;D ·,t = P r {D i,t = 1} = P r {E i ≤ t} is the share of treated units at time t;D e,· = T −e T +1 is the share of treated periods; andD =
is fixed for all i. We thus have
The equality inside the braces of (11) follows from no anticipation (Assumption 2). The equality inside the braces of (12) follows from parallel trends and no anticipation (Assumption 1 and 2).
Furthermore, we have
With this, we can distribute E Y ∞ i,t − Y ∞ i,0 across the treated units and obtain the following expression:
To see that the weights sum up to one, note that the denominator of the weights can be written as
Proof of Proposition 2
Proof. Following a similar argument in the proof for Proposition 1, the projection coefficients µ l 's from regression (3) are:
and again,Ẍ i,t is time-and cross-sectional demeaned version of X i,t .
14 To further develop the expression for the projection coefficients µ l 's, we note that 14 Note that T −1 l=−TD l i,t = 0 and we need to drop oneD l i,t due to multicollinearity. Another multicollinearity is are two lead indicators i.e. l < 0.
Under the parallel trends and no anticipation assumptions, we have E Y
Thus the expression for projection coefficients µ l 's now simplifies to
Furthermore, we can write
. . .
Ei−1 |E i to zero by the no anticipation assumption. For index that is out of range e.g. e + l < 0 or e + l > T , even though
is undefined, the above expression is well-defined because the corresponding D l i,t = 0 for all t. Using this expression, the expression for projection coefficients µ l 's simplifies to
While D i,t D i,t is a diagonal matrix with diagonal entries equal to one for t = E i + l and zero otherwise, 
B Simulation design
We generate 1000 simulated datasets with N = 1000 and T = 3 according to the following DGP Y i,t = i + t + For each simulation, we draw E i uniformly from {1, 2, 3}. We analyze the case where the DGP is a model of dynamic and non-stationary treatment effects. In particular, we set δ 1,0 = 2, δ 1,1 = 18, δ 1,2 = 19, δ 2,0 = 3, δ 2,1 = 4, δ 3,0 = 4, δ e,l<0 = 0 ∀e and i,t ∼ N (0, 1). For each simulation, we estimate
While δ u,−1 = 0 ∀u and hence CAT T e,−1 = 0 for all e, the estimatesμ −1 's are usually negative as shown in Figure 1 , which would suggest a negative pre-trend.
C Including covariates and doubly robust scores for event studies
When there are covariate-specific time trends, we need to modify the unconditional parallel trends assumption to the following one. Denote the confounding covariates by X i,t . We maintain the no anticipation assumption, but again allow the treatment effects to be dynamic for all cohorts and heterogenous i.e. non-stationary.
The causal parameter of interest is still Suppose we know the probability of being in cohort e = t − l conditional on X i,t , denoted by m 0 (X i,t ) := P r {E i = t − l|X i,t }, and the probability of not having received treatment by time t conditional on X i,t , denoted by n 0 (X i,t ) := P r {E i > t|X i,t }, as well as the share of cohort e, m 0 := P r {E i = t − l} . Then we can form a consistent estimator for θ 0 by
This inverse propensity score reweighted estimator is an extension to Abadie (2005) . A similar version has been proposed by Callaway and Sant'Anna (2018) . Collect η 0 (X i,t ) := E Y ∞ i,t − Y ∞ i,0 | X i,t , P r {E i = t − l|X i,t } , P r {E i > t|X i,t } , P r {E i = t − l} Let η (X i,t ) := (g ∞ (X i,t ) , m (X i,t ) , n (X i,t ) , m) denote the nuisance parameter with true value η 0 (X i,t ).
In practice, it is likely that we make mistakes in estimating η (X i,t ). We may employ the following doubly robust score as an extension to the doubly robust score derived for cross-sectional models. Define
where W i := (Y i,t , Y i,0 , X i,t ).
We can show that the score satisfies the identification condition E [ψ (W i , θ 0 , η 0 )] = 0 and the Neyman orthogonality condition ∂ η E [ψ (W i , θ 0 , η)] η=η0 = 0 . This score is robust to small mistakes in η (X i,t ). The estimation can be done by K-fold cross-fitting as described in Chernozhukov et al. (2017) .
For X i,t = 1, we are back to the unconditional parallel trends assumption. The DID estimator with s = 0 and C = {c : t < c} is the root θ of the above doubly robust score in the sample, E N [ψ (W i , θ, η)] = 0, where η is the sample analog of η 0 .
